Document is current
Any future updates will be listed below
-
Authors
Braun, Urs https://orcid.org/0000-0002-6290-3630
Harneit, Anais
Pergola, Giulio
Menara, Tommaso https://orcid.org/0000-0002-5523-2170
Schäfer, Axel
Betzel, Richard F. https://orcid.org/0000-0001-9200-1681
Zang, Zhenxiang
Schweiger, Janina I.
Zhang, Xiaolong
Schwarz, Kristina
Chen, Junfang
Blasi, Giuseppe
Bertolino, Alessandro
Durstewitz, Daniel
Pasqualetti, Fabio https://orcid.org/0000-0002-8457-8656
Schwarz, Emanuel https://orcid.org/0000-0002-0261-5063
Meyer-Lindenberg, Andreas
Bassett, Danielle S. https://orcid.org/0000-0002-6183-4493
Tost, Heike https://orcid.org/0000-0002-7339-7569
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (BR 5951/1-1)
- License Information
-
More Information
Article History
Received: 26 October 2019
Accepted: 27 April 2021
First Online: 9 June 2021
Competing interests
: A.M.-L. has received consultant fees from Blueprint Partnership, Boehringer Ingelheim, Daimler und Benz Stiftung, Elsevier, F. Hoffmann-La Roche, ICARE Schizophrenia, K. G. Jebsen Foundation, L.E.K Consulting, Lundbeck International Foundation (LINF), R. Adamczak, Roche Pharma, Science Foundation, Synapsis Foundation – Alzheimer Research Switzerland, System Analytics, and has received lectures including travel fees from Boehringer Ingelheim, Fama Public Relations, Institut d’investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Janssen-Cilag, Klinikum Christophsbad, Göppingen, Lilly Deutschland, Luzerner Psychiatrie, LVR Klinikum Düsseldorf, LWL PsychiatrieVerbund Westfalen-Lippe, Otsuka Pharmaceuticals, Reunions i Ciencia S. L., Spanish Society of Psychiatry, Südwestrundfunk Fernsehen, Stern TV, and Vitos Klinikum Kurhessen. A.B. has received consultant fees from Biogen and speaker fees from Lundbeck, Otsuka, Recordati, and Angelini. The remaining authors declare no competing interest.
